GBP1 and breast carcinoma: The recent finding that GBP-1 can be unregulated in breast cancer cell lines by epidermal growth factor receptor (EGFR) signaling might provide clues on why GBP-1 is not protective when all types of breast cancers are considered as a group (Figure 1) [20].